Who we are
Futura specialises in the development and global commercialisation of innovative and proprietary sexual health products. Our lead product is Eroxon®, a clinically proven breakthrough treatment for erectile dysfunction (“ED”). Our purpose is to provide a range of clinically proven sexual health products that enhance quality of life.
Our Commercial Model
Futura’s business model is based on an ‘actively manage and optimise’ approach focused on a hybrid R&D and commercial approach which will provide greater flexibility, insight development and sharing and improved economic participation across markets.
Board of Directors
The Board has the overall responsibility to set the strategy for the Group and ensure that the Group delivers long term value to its shareholders.